Euphemia Y Leung (Euphemia Leung)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 33

Top Topics

Molecular Docking

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Expert review of clinical immunology

Molecules (Basel, Switzerland)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Gao, Andrew N Shelling, Emma Nolan, David Porter, Euphemia Y Leung, Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells. Journal of liposome research (2024)
Zdravko Odak, Sandra Marijan, Mila Radan, Lisa Ivy Pilkington, Monika Čikeš Botić, David Barker, Jóhannes Reynisson, Euphemia Y Leung, Vedrana Čikeš Čulić
Deciphering the Interplay: Thieno[2,3- b ]pyridine's Impact on Glycosphingolipid Expression, Cytotoxicity, Apoptosis, and Metabolomics in Ovarian Tumor Cell Lines. International journal of molecular sciences 25 (13) (2024)
Yu Gao, Andrew N Shelling, Emma Nolan, David Porter, Euphemia Y Leung, Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells. Journal of liposome research 34 (3) (2024)
Zdravko Odak, Sandra Marijan, Mila Radan, Lisa Ivy Pilkington, Monika Čikeš Botić, David Barker, Jóhannes Reynisson, Euphemia Y Leung, Vedrana Čikeš Čulić
Deciphering the Interplay: Thieno[2,3- b ]pyridine's Impact on Glycosphingolipid Expression, Cytotoxicity, Apoptosis, and Metabolomics in Ovarian Tumor Cell Lines. International journal of molecular sciences 25 (13) (2024)
Emily K Paulin, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9' Derivatisation. International journal of molecular sciences 24 (2) (2023)
Shaun W P Rees, Hayden Jones-Moore, Euphemia Y Leung, David Barker, Lisa Ivy Pilkington
Investigation of 2-phenylimidazo[1,2- a ]quinolines as potential antiproliferative agents. Future medicinal chemistry 15 (3) (2023)
Shaun W P Rees, Hayden Jones-Moore, Euphemia Y Leung, David Barker, Lisa Ivy Pilkington
Investigation of 2-phenylimidazo[1,2- a ]quinolines as potential antiproliferative agents. Future medicinal chemistry (2023)
Emily K Paulin, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9' Derivatisation. International journal of molecular sciences 24 (2) (2023)
Bailey Morphet, Shaun W P Rees, Natalie A Haverkate, Hamid Aziz, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Synthesis and Anti-Proliferative Activity of 5-Benzoyl and 5-Benzylhydroxy Derivatives of 3-Amino-2-Arylcarboxamido-Thieno[2-3- b ]Pyridines. International journal of molecular sciences 24 (14) (2023)
Emily K Paulin, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9' Derivatisation. International journal of molecular sciences 24 (2) (2023)
Yu Gao, Andrew N Shelling, David Porter, Euphemia Y Leung, Zimei Wu
Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis. Pharmaceutical development and technology (2023)
Emily K Paulin, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9' Derivatisation. International journal of molecular sciences 24 (2) (2023)
Shaun W P Rees, Hayden Jones-Moore, Euphemia Y Leung, David Barker, Lisa Ivy Pilkington
Investigation of 2-phenylimidazo[1,2- a ]quinolines as potential antiproliferative agents. Future medicinal chemistry 15 (3) (2023)
Peter Jaein Choi, Petr Tomek, Moana Tercel, Jóhannes Reynisson, Thomas In Hyeup Park, Elizabeth Alexandra Cooper, William Alexander Denny, Jiney Jose, Euphemia Y Leung
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action. Molecules (Basel, Switzerland) 27 (3) (2022)
Emily K Paulin, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
The enantioselective total syntheses of (+)-7-oxohinokinin, (+)-7-oxoarcitin, (+)-conicaol B and (-)-isopolygamain. Organic & biomolecular chemistry 20 (21) (2022)
Natalie A Haverkate, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Disruption of Crystal Packing in Thieno[2,3- b ]pyridines Improves Anti-Proliferative Activity. Molecules (Basel, Switzerland) 27 (3) (2022)
Gary J Cheng, Euphemia Y Leung, Dean C Singleton
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Rohan Ameratunga, See-Tarn Woon, Edward Lea, Richard Steele, Klaus Lehnert, Euphemia Y Leung, Anna E S Brooks
The (apparent) antibody paradox in COVID-19. Expert review of clinical immunology 18 (4) (2022)
Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Y Leung, Anna E S Brooks
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Expert review of clinical immunology 18 (6) (2022)
Stephen Lo, Euphemia Y Leung, Bruno Fedrizzi, David Barker
Synthesis, Antiproliferative Activity and Radical Scavenging Ability of 5-O-Acyl Derivatives of Quercetin. Molecules (Basel, Switzerland) 26 (6) (2021)
Euphemia Y Leung, Jinal Patel, Jennifer A Hollywood, Ayesha Zafar, Petr Tomek, David Barker, Lisa Ivy Pilkington, Michelle van Rensburg, Ries J Langley, Nuala Ann Helsby, Christopher J Squire, Bruce C Baguley, William Alexander Denny, Jóhannes Reynisson, Ivanhoe K H Leung
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs. Oncology and therapy 9 (2) (2021)
Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, Hilary Longhurst, Euphemia Y Leung, Richard Steele, Klaus Lehnert, Russell Snell, Anna E S Brooks
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection. Expert review of clinical immunology 17 (5) (2021)
Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, Hilary Longhurst, Euphemia Y Leung, Richard Steele, Klaus Lehnert, Russell Snell, Anna E S Brooks
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19. Expert review of clinical immunology 17 (11) (2021)
Natalie A Haverkate, Euphemia Y Leung, Lisa Ivy Pilkington, David Barker
Tethered Aryl Groups Increase the Activity of Anti-Proliferative Thieno[2,3- b ]Pyridines by Targeting a Lipophilic Region in the Active Site of PI-PLC. Pharmaceutics 13 (12) (2021)
Shaun W P Rees, Tayla A Rees, Euphemia Y Leung, Christopher S Walker, David Barker, Lisa I Pilkington
Incorporation of a Nitric Oxide Donating Motif into Novel PC-PLC Inhibitors Provides Enhanced Anti-Proliferative Activity. International journal of molecular sciences 22 (21) (2021)
Rohan Ameratunga, See-Tarn Woon, Richard Steele, Russell Snell, Natalie Medlicott, Emily Mears, Euphemia Y Leung, Klaus Lehnert, Anthony Jordan, Shyamal Das, William Abbott, Hilary Longhurst, Miguel E Quiñones-Mateu
Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection. Expert review of clinical immunology 17 (6) (2021)
Nabangshu Sharma, Ries J Langley, Chatchakorn Eurtivong, Euphemia Y Leung, Ryan Joseph Dixon, Emily K Paulin, Shaun W P Rees, Lisa Ivy Pilkington, David Barker, Jóhannes Reynisson, Ivanhoe K H Leung
An optimised MALDI-TOF assay for phosphatidylcholine-specific phospholipase C. Analytical methods : advancing methods and applications 13 (4) (2021)
Yu Gao, Mingtan Tang, Euphemia Y Leung, Darren Svirskis, Andrew N Shelling, Zimei Wu
Dual or multiple drug loaded nanoparticles to target breast cancer stem cells. RSC advances 10 (32) (2020)
Colin L Hisey, Petr Tomek, Yohanes N S Nursalim, Lawrence Willam Chamley, Euphemia Y Leung
Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancer. F1000Research 9 (2020)
Tzu-Yu Lin, Hsiu-Han Chan, Shang-Hung Chen, Sailu Sarvagalla, Pai-Sheng Chen, Mohane Selvaraj Coumar, Siao Muk Cheng, Yung-Chieh Chang, Chun-Hui Lin, Euphemia Y Leung, Chun Hei Antonio Cheung
BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 16 (7) (2019)
Euphemia Y Leung, Lisa Ivy Pilkington, Mohinder M Naiya, David Barker, Ayesha Zafar, Chatchakorn Eurtivong, Jóhannes Reynisson
The cytotoxic potential of cationic triangulenes against tumour cells. MedChemComm 10 (11) (2019)
Shahida Parveen, Muhammad Hanif, Euphemia Y Leung, Kelvin K H Tong, Annie Yang, Jonathan Astin, Gayan Heruka De Zoysa, Tasha R Steel, David Goodman, Sanam Movassaghi, Tilo Söhnel, Vijayalekshmi Sarojini, Stephen M F Jamieson, Christian G Hartinger
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity. Chemical communications (Cambridge, England) 55 (80) (2019)
Jóhannes Reynisson, Jagdish K Jaiswal, David Barker, Stacey A N D'mello, William A Denny, Bruce C Baguley, Euphemia Y Leung
Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative. Cancer cell international 16 (2016)
Euphemia Y Leung, Ji Eun Kim, Marjan Askarian-Amiri, Graeme J Finlay, Bruce C Baguley
Evidence for the existence of triple-negative variants in the MCF-7 breast cancer cell population. BioMed research international 2014 (2014)